Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Diagnosis and treatment of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea.

Yun JW, Lim SY, Suh GY, Chung MP, Kim H, Kwon OJ, Cha HS, Koh EM, Koh WJ.

J Korean Med Sci. 2007 Oct;22(5):779-83.

2.

Interferon-γ release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea.

Chang B, Park HY, Jeon K, Ahn JK, Cha HS, Koh EM, Kang ES, Koh WJ.

Clin Rheumatol. 2011 Dec;30(12):1535-41. doi: 10.1007/s10067-011-1771-9. Epub 2011 May 10.

PMID:
21556777
3.

QuantiFERON-TB Gold In-Tube assay for screening arthritis patients for latent tuberculosis infection before starting anti-tumor necrosis factor treatment.

Lee H, Park HY, Jeon K, Jeong BH, Hwang JW, Lee J, Cha HS, Koh EM, Kang ES, Koh WJ.

PLoS One. 2015 Mar 6;10(3):e0119260. doi: 10.1371/journal.pone.0119260. eCollection 2015.

4.

Incidence of tuberculosis among anti-tumor necrosis factor users in patients with a previous history of tuberculosis.

Jo KW, Hong Y, Jung YJ, Yoo B, Lee CK, Kim YG, Yang SK, Byeon JS, Kim KJ, Ye BD, Lee SD, Kim WS, Kim DS, Shim TS.

Respir Med. 2013 Nov;107(11):1797-802. doi: 10.1016/j.rmed.2013.08.011. Epub 2013 Aug 28.

5.

The evaluation of latent tuberculosis in rheumatologic diseases for anti-TNF therapy: experience with 192 patients.

Hanta I, Ozbek S, Kuleci S, Kocabas A.

Clin Rheumatol. 2008 Sep;27(9):1083-6. doi: 10.1007/s10067-008-0867-3. Epub 2008 Mar 5.

PMID:
18320137
6.

Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay.

Kim HC, Jo KW, Jung YJ, Yoo B, Lee CK, Kim YG, Yang SK, Byeon JS, Kim KJ, Ye BD, Shim TS.

Scand J Infect Dis. 2014 Nov;46(11):763-9. doi: 10.3109/00365548.2014.938691. Epub 2014 Sep 8.

PMID:
25195652
7.

Agreement between Quantiferon-TB gold test and tuberculin skin test in the identification of latent tuberculosis infection in patients with rheumatoid arthritis and ankylosing spondylitis.

Inanc N, Aydin SZ, Karakurt S, Atagunduz P, Yavuz S, Direskeneli H.

J Rheumatol. 2009 Dec;36(12):2675-81. doi: 10.3899/jrheum.090268. Epub 2009 Nov 16.

PMID:
19918035
8.

[Recommendations for the diagnosis and treatment of latent and active tuberculosis in patients with inflammatory joint diseases treated with tumour necrosis factor alpha inhibitors].

Fonseca JE, Lucas H, Canhão H, Duarte R, Santos MJ, Villar M, Faustino A, Raymundo E; Grupo de Estudos de Artrite Reumatóide da Sociedade Portuguesta de Reumatologia; Comissão de Tuberculose da Sociedade Portuguesa de Pneumologia.

Acta Reumatol Port. 2006 Jul-Sep;31(3):237-45. Portuguese.

9.

Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.

Ponce de Leon D, Acevedo-Vasquez E, Alvizuri S, Gutierrez C, Cucho M, Alfaro J, Perich R, Sanchez-Torres A, Pastor C, Sanchez-Schwartz C, Medina M, Gamboa R, Ugarte M.

J Rheumatol. 2008 May;35(5):776-81. Epub 2008 Apr 1.

PMID:
18398944
10.

LTBI screening in rheumatoid arthritis patients prior to anti-TNF treatment in an endemic area.

Bonfiglioli KR, Ribeiro AC, Moraes JC, Saad CG, Souza FH, Calich AL, Bonfa E, Laurindo IM.

Int J Tuberc Lung Dis. 2014 Aug;18(8):905-11. doi: 10.5588/ijtld.13.0755. Erratum in: Int J Tuberc Lung Dis. 2014 Sep;18(9):1134.

PMID:
25199003
11.

[Guidelines for the diagnosis and treatment of latent tuberculosis infection and active tuberculosis in patients with inflammatory joint diseases proposed for treatment with tumour necrosis factor alpha antagonist drugs].

Fonseca JE, Lucas H, Canhão H, Duarte R, Santos MJ, Villar M, Faustino A, Raymundo E; Sociedade Portuguesa de Reumatologia; Sociedade Portuguesa de Pneumologia.

Rev Port Pneumol. 2006 Sep-Oct;12(5):603-13. Review. Portuguese.

PMID:
17117328
12.

Intermediate to long-term follow-up results of INH chemoprophylaxis prior to anti-TNF-alpha therapy in a high-risk area for tuberculosis.

Kurt OK, Kurt B, Talay F, Tug T, Soy M, Bes C, Hayran M.

Wien Klin Wochenschr. 2013 Oct;125(19-20):616-20. doi: 10.1007/s00508-013-0417-0. Epub 2013 Sep 6.

PMID:
24061693
13.

Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial.

Park JH, Seo GY, Lee JS, Kim TH, Yoo DH.

J Rheumatol. 2009 Oct;36(10):2158-63. doi: 10.3899/jrheum.090150. Epub 2009 Sep 1.

PMID:
19723901
14.

Interferon-γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis.

Sauzullo I, Mengoni F, Marocco R, Potenza C, Skroza N, Tieghi T, Lichtner M, Vullo V, Mastroianni CM.

Br J Dermatol. 2013 Nov;169(5):1133-40. doi: 10.1111/bjd.12544.

PMID:
23909256
15.

[Recommendations for the prevention and management of tuberculosis in patients treated with tumor necrosis factor alpha inhibitors: a consensus of lithuanian pulmonologists and rheumatologists].

Malakauskas K, Zablockis R, Venalis A, Butrimienė I, Baranauskaitė A, Nargėla RV, Sakalauskas R.

Medicina (Kaunas). 2011;47(3):187-91. Lithuanian.

16.

Tuberculosis infection in rheumatic patients with infliximab therapy: experience with 157 patients.

Nobre CA, Callado MR, Lima JR, Gomes KW, Martiniano GV, Vieira WP.

Rheumatol Int. 2012 Sep;32(9):2769-75. doi: 10.1007/s00296-011-2017-5. Epub 2011 Aug 7.

PMID:
21822912
17.

Mycobacterial infections in patients treated with tumor necrosis factor antagonists in South Korea.

Lee SK, Kim SY, Kim EY, Jung JY, Park MS, Kim YS, Kim SK, Chang J, Kang YA.

Lung. 2013 Oct;191(5):565-71. doi: 10.1007/s00408-013-9481-5. Epub 2013 Jun 1.

PMID:
23728990
18.
19.

Repeated tuberculin skin testing following therapy with TNF-alpha inhibitors.

Fuchs I, Avnon L, Freud T, Abu-Shakra M.

Clin Rheumatol. 2009 Feb;28(2):167-72. doi: 10.1007/s10067-008-1007-9. Epub 2008 Sep 16.

PMID:
18795393
20.

Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy.

Sellam J, Hamdi H, Roy C, Baron G, Lemann M, Puéchal X, Breban M, Berenbaum F, Humbert M, Weldingh K, Salmon D, Ravaud P, Emilie D, Mariette X; RATIO (Research Axed on Tolerance of Biotherapies) Study Group.

Ann Rheum Dis. 2007 Dec;66(12):1610-5. Epub 2007 Apr 24.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk